Network Pharmacology and Molecular Analysis of Mechanisms Underlying the Therapeutic Effects of Rhubarb in Treating Atherosclerosis and Abdominal Aortic Aneurysm

Overview

Journal Heliyon

Specialty Social Sciences

Date 2025 Mar 3

PMID 40028580

Authors

Huilin Xu

Jun Huang

Youjie Zeng

Xia Wang

Huilin Lian

Siyi Zhang

Ren Guo

Affiliations

Soon will be listed here.

Abstract

Aim Of The Study: The aim of this study was to systematically investigate the effects and mechanisms of Rhubarb in the treatment of Atherosclerosis (AS) and Abdominal Aortic Aneurysm (AAA) by utilizing network pharmacology and molecular docking techniques.

Materials And Methods: TCMSP systematic pharmacology database was utilized to search for active chemical components of Rhubarb. Disease-related targets were retrieved from the GEO dataset and Disgenet database. Gene interactions were utilized to identify common targets of Rhubarb with AS/AAA, and interaction networks were constructed using Cytoscape 3.9.1. Protein-protein interaction (PPI) networks for the core targets were constructed using the STRING database. GO and KEGG pathway enrichment analysis was performed using DAVID. Molecular docking is used to assess the potential target-active compound interactions.

Results: In our study, 16 active compounds were screened from Rhubarb along with 310 targets. Additionally, 110 AS/AAA target genes were screened out. Topological analysis of the PPI protein network yielded 23 core targets. The targets, biological functions and signaling pathways of Rhubarb in AS/AAA were further investigated. The analysis indicated that Rhubarb may be effective in treating AS/AAA through processes such as lipids, atherosclerosis, extracellular matrix catabolism, collagenolytic metabolic processes, and the extracellular environment. Five core pharmacological targets were also identified: TNF, IL-1β MMP9, TP53, and PPARG. Molecular docking showed a strong binding ability between the active compounds and the screened targets.

Conclusions: This study successfully predicted the molecular functions, pharmacological targets, and pathways associated with Rhubarb for treating AS/AAA. In addition, identified potential active ingredients can be used as a source for AS/AAA drug screening.

References

Carmo H, Castillo A, Bonilha I, Gomes E, Barreto J, Moura F . Diacerein reduces inflammasome activation and SARS-CoV-2 virus replication: a proof-of-concept translational study. Front Pharmacol. 2024; 15:1402032. PMC: 11491754. DOI: 10.3389/fphar.2024.1402032. View

Lei Y, Fu X, Chen M, Yi Y, Mao P, Peng L . Dahuang-Taoren, a botanical drug combination, ameliorates adenomyosis inhibiting Rho GTPases. Front Pharmacol. 2023; 14:1089004. PMC: 10035534. DOI: 10.3389/fphar.2023.1089004. View

Jin Z, Wei Z . Molecular simulation for food protein-ligand interactions: A comprehensive review on principles, current applications, and emerging trends. Compr Rev Food Sci Food Saf. 2024; 23(1):e13280. DOI: 10.1111/1541-4337.13280. View

Chatterjee P, Martin K . A Concept of "Athero-Oncology": Tumor-Like Smooth Muscle Cells Drive Atherosclerosis. Circulation. 2024; 149(24):1899-1902. DOI: 10.1161/CIRCULATIONAHA.124.069446. View

Qin M, Huang S, Zou X, Zhong X, Yang Y, Zhang Y . Drug-containing serum of rhubarb-astragalus capsule inhibits the epithelial-mesenchymal transformation of HK-2 by downregulating TGF-β1/p38MAPK/Smad2/3 pathway. J Ethnopharmacol. 2021; 280:114414. DOI: 10.1016/j.jep.2021.114414. View

Liu Q, Ba X, Han L, Yan J, Chen Z, Qin K . Dahuang-Wumei decoction protects against hepatic encephalopathy in mice: Behavioural, biochemical, and molecular evidence. Phytomedicine. 2024; 128:155419. DOI: 10.1016/j.phymed.2024.155419. View

Zhu G, Cao L, Wu J, Xu M, Zhang Y, Wu M . Co-morbid intersections of cancer and cardiovascular disease and targets for natural drug action: Reprogramming of lipid metabolism. Biomed Pharmacother. 2024; 176:116875. DOI: 10.1016/j.biopha.2024.116875. View

Pacheco G, Lopes A, Oliveira A, Correa W, Lima L, de Souza M . Comprehensive analysis of gastrointestinal side effects in COVID-19 patients undergoing combined pharmacological treatment with azithromycin and hydroxychloroquine: a systematic review and network meta-analysis. Crit Rev Toxicol. 2024; 54(6):345-358. DOI: 10.1080/10408444.2024.2348169. View

Wu J, Ke X, Wang W, Zhang H, Ma N, Fu W . Aloe-emodin suppresses hypoxia-induced retinal angiogenesis inhibition of HIF-1α/VEGF pathway. Int J Biol Sci. 2016; 12(11):1363-1371. PMC: 5118782. DOI: 10.7150/ijbs.16334. View

10.

Xu C, Yin C, Wang S . Effect of aloe-emodin on expression of proliferating cell nuclear antigen of vascular smooth muscle cells in culture after arterial injury. Chin Med J (Engl). 2002; 114(6):571-6. View

11.

Xiao S, Zhang Z, Chen M, Zou J, Jiang S, Qian D . Xiexin Tang ameliorates dyslipidemia in high-fat diet-induced obese rats via elevating gut microbiota-derived short chain fatty acids production and adjusting energy metabolism. J Ethnopharmacol. 2019; 241:112032. DOI: 10.1016/j.jep.2019.112032. View

12.

Geng J, Zhou G, Guo S, Ma C, Ma J . Underlying Mechanism of Traditional Herbal Formula Chuang-Ling-Ye in the Treatment of Diabetic Foot Ulcer through Network Pharmacology and Molecular Docking. Curr Pharm Des. 2024; 30(6):448-467. DOI: 10.2174/0113816128287155240122121553. View

13.

Yang Q, Saaoud F, Lu Y, Pu Y, Xu K, Shao Y . Innate immunity of vascular smooth muscle cells contributes to two-wave inflammation in atherosclerosis, twin-peak inflammation in aortic aneurysms and trans-differentiation potential into 25 cell types. Front Immunol. 2024; 14:1348238. PMC: 10847266. DOI: 10.3389/fimmu.2023.1348238. View

14.

Mori M, Sakamoto A, Kawakami R, Guo L, Slenders L, Mosquera J . CD163 Macrophages Induce Endothelial-to-Mesenchymal Transition in Atheroma. Circ Res. 2024; 135(2):e4-e23. DOI: 10.1161/CIRCRESAHA.123.324082. View

15.

Sapkota M, Shrestha S, Yang M, Park Y, Soh Y . Aloe-emodin inhibits osteogenic differentiation and calcification of mouse vascular smooth muscle cells. Eur J Pharmacol. 2019; 865:172772. DOI: 10.1016/j.ejphar.2019.172772. View

16.

Chen C, Gu J, Wang J, Wu Y, Yang A, Chen T . Physcion 8-O-β-glucopyranoside ameliorates liver fibrosis through inflammation inhibition by regulating SIRT3-mediated NF-κB P65 nuclear expression. Int Immunopharmacol. 2020; 90:107206. DOI: 10.1016/j.intimp.2020.107206. View

17.

Zhao W, Li B, Hao J, Sun R, He P, Lv H . Therapeutic potential of natural products and underlying targets for the treatment of aortic aneurysm. Pharmacol Ther. 2024; 259:108652. DOI: 10.1016/j.pharmthera.2024.108652. View

18.

Cho M, Lee M, Park J . Aortic aneurysms: current pathogenesis and therapeutic targets. Exp Mol Med. 2023; 55(12):2519-2530. PMC: 10766996. DOI: 10.1038/s12276-023-01130-w. View

19.

Chen Y, Tu Y, Cao J, Wang Y, Ren Y . Rhein Alleviates Doxorubicin-Induced Myocardial Injury by Inhibiting the p38 MAPK/HSP90/c-Jun/c-Fos Pathway-Mediated Apoptosis. Cardiovasc Toxicol. 2024; 24(11):1139-1150. DOI: 10.1007/s12012-024-09917-7. View

20.

Li B, Bao J, Huang Y, Liu J, Yan X, Zou Q . Dual-Integrin-Targeted Supramolecular Peptide Nanoarchitectonics for Enhanced Hepatic Delivery and Antifibrotic Therapy. Small. 2024; :e2409038. DOI: 10.1002/smll.202409038. View